MiR-301a is highly expressed in human pancreatic cancer patients, which can target SOCS5 to activate JAK/STAT3 and promote the migration and invasion of pancreatic cancer cells [60]. This evidence concerns the gene SOCS5 and pancreatic neoplasm.